Alps Advisors Inc Bio Xcel Therapeutics, Inc. Transaction History

Alps Advisors Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$17.7 - $33.24 $9,487 - $17,816	-536 Reduced 2.82%	18,458 $344,000
Q4 2022 Feb 14, 2023	BUY	$10.25 - $22.43 $38,417 - $84,067	3,748 Added 24.58%	18,994 $407,000
Q3 2022 Nov 14, 2022	SELL	$11.19 - $17.89 $15,106 - $24,151	-1,350 Reduced 8.13%	15,246 $180,000
Q2 2022 Aug 11, 2022	SELL	$9.03 - $21.55 $109,786 - $262,004	-12,158 Reduced 42.28%	16,596 $219,000
Q1 2022 May 16, 2022	SELL	$15.0 - $22.83 $54,315 - $82,667	-3,621 Reduced 11.18%	28,754 $601,000
Q4 2021 Feb 09, 2022	SELL	$20.12 - $35.09 $38,288 - $66,776	-1,903 Reduced 5.55%	32,375 $658,000
Q3 2021 Nov 15, 2021	BUY	$23.84 - $32.03 $43,865 - $58,935	1,840 Added 5.67%	34,278 $1.04 Million
Q2 2021 Aug 11, 2021	SELL	$29.06 - $38.83 $338,316 - $452,058	-11,642 Reduced 26.41%	32,438 $943,000
Q1 2021 May 07, 2021	BUY	$39.04 - $64.6 $12,492 - $20,672	320 Added 0.73%	44,080 $1.9 Million
Q4 2020 Feb 03, 2021	BUY	$42.46 - $56.58 $647,557 - $862,901	15,251 Added 53.5%	43,760 $2.02 Million
Q3 2020 Nov 04, 2020	BUY	$37.44 - $64.63 $35,156 - $60,687	939 Added 3.41%	28,509 $1.24 Million
Q2 2020 Aug 05, 2020	BUY	$17.62 - $58.71 $485,783 - $1.62 Million	27,570 New	27,570 $1.46 Million

3.14M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $9.81M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.